UC San Diego SearchMenu

COVID 19 Research Community Impact

Read news about how COVID-19 research at UC San Diego is helping our local community and the nation.

UC San Diego researchers are working around the clock to address the many challenges of COVID-19, from testing and treatments to high performance computing and devices. Here is a sample of some of the research we are doing and the impact it is having in our local community and around the world.

  • (6/18/20) To Wear a Mask or Not, Is Not the Question; Research Indicates It’s the Answer:

    A team of scientists from the University of California San Diego, Caltech and Texas A&M remotely put their heads together to analyze the transmission pathways of COVID-19. Their study confirms that face coverings determine the pandemic’s trends and significantly reduce the number of infections.  Read the full story.

  • (6/1/20) Fighting COVID-19 with Knowledge Graphs:

    Two researchers at the San Diego Supercomputer Center (SDSC) were awarded funding to organize COVID-19 information into a transdisciplinary knowledge network that integrates health, pathogen, and environmental data to better track cases to improve analysis and forecasting across the greater San Diego region.  Read the full story.

  • (5/28/20) Forecasting a Pandemic:

    Infectious disease modeler predicts how interventions limit spread of COVID-19 in San Diego, including as part of campus Return to Learn program.  Read the full story.

  • (5/19/20) eCOVID Platform Provides Remote Patient Monitoring:

    Engineers at the University of California San Diego have developed a remote monitoring platform for patients who have tested positive for COVID-19 but aren’t in need of hospitalization.  Read the full story.

  • (5/15/20) NIH Begins Clinical Trial of Hydroxychloroquine and Azithromycin to Treat COVID-19:

    The National Institutes of Health (NIH) has launched a much-anticipated Phase IIb clinical trial to evaluate whether the malaria drug hydroxychloroquine in combination with the antibiotic azithromycin can prevent hospitalization and death from COVID-19.  Read the full story.

  • (5/14/20) New Algorithm Analyzes the Genetic Building Blocks of Immunity:

    Scientists with UC San Diego’s Jacobs School of Engineering and the Qualcomm Institute have developed a new gene prediction algorithm, called MINING-D, that could help researchers investigate the genetic clues behind the variation of symptoms shown in COVID-19 patients — information that is key to creating a versatile and effective vaccine. Read the full story.

  • (5/05/20) Introducing the UC San Diego Return to Learn Program:

    Program makes COVID-19 testing available to thousands of students in effort to track the novel coronavirus and better position the campus to resume in-person activities in the fall. Read the full story.

  • (5/05/20) Researchers Hope to Measure Well-Being at Global Scale:

    With website, UC San Diego School of Medicine scientists will monitor health and well-being during and after pandemic. Read the full story.

  • (5/1/20) Green Method Could Enable Hospitals to Produce Hydrogen Peroxide In House: A team of researchers has developed a portable, more environmentally friendly method to produce hydrogen peroxide. It could enable hospitals to make their own supply of the disinfectant on demand and at lower cost. Read the full story.
  • (4/30/20) Clinical Trial to Investigate whether Hypertension Drug Ameliorates COVID-19 Severity:

    ACE inhibitor drugs like Ramipril are widely used for various cardiovascular conditions; researchers want to see if they might also provide benefit to patients infected by SARS-CoV-2. Read the full story.

  • (4/29/20) Arthritis Drug Presents Promise as Treatment for COVID-19 Pneumonia:

    Clinical trials at UC San Diego Health and elsewhere will assess whether tocilizumab can reduce out-of-control inflammation that damages lungs and increases risks for ventilation and death. Read the full story.

  • (4/23/20) Coronavirus Global Slowdown Is Cleaning the Skies. How Long Will It Last?

    Scripps Oceanography climate scientists ponder what episode tells us about global warming. Read the full story.

  • (4/20/20) Marrying Molecular Farming and Advanced Manufacturing to Develop a COVID-19 Vaccine:

    Nanoengineers at the University of California San Diego are working on a COVID-19 vaccine using plants to create a stable, easy to manufacture vaccine that can be shipped around the globe. Read the full story.

  • (4/17/20) UC San Diego Health Launches Novel Coronavirus Blood Testing to Identify Past Exposure:

    Serological tests look for antibodies produced in response to infection, and will help determine who may have potentially acquired immunity to COVID-19 and who remains at risk. Read the full story.

  • (4/16/20) Startup Companies Tackle COVID-19 From Many Angles: Companies that found their footing at the Qualcomm Institute Innovation Space are working to model disease outbreaks, increase access to offline education and facilitate research on COVID-19. Read the full story.

  • (4/15/20) SDSC Researchers Develop Potential COVID-19 Protease Inhibitors: 

    Repurposing certain FDA-approved drugs could help counter coronavirus.  San Diego Supercomputer Center recently created a pharmacophore model and conducted data mining of the conformational database of FDA-approved drugs that identifies 64 compounds as potential inhibitors of the COVID-19 protease. Read the full story.

  • (4/13/20) Loss of Smell and Taste Validated as COVID-19 Symptoms: Study suggests clinicians should include sensory impairment as standard screening measure. Read the full story.

  • (4/9/20) Call for Citizen Scientists to Contribute to COVID-19 Studies: The Microsetta Initiative, a crowdsourced research effort based at the University of California San Diego School of Medicine, has expanded its capabilities to now allow citizen-scientists around the world to help collect crucial information about SARS-CoV-2, the novel coronavirus causing a COVID-19 pandemic. Read the full story.

  • (4/7/20) Artificial Intelligence Enables Rapid COVID-19 Lung Imaging Analysis at UC San Diego Health: With support from Amazon Web Services, health care providers are using AI in a clinical research study aimed at speeding the detection of pneumonia, a condition associated with severe COVID-19. Read the full story.

  • (4/6/20) Tested and Testing: UC San Diego Health Expands COVID-19 Diagnostics: Teams of doctors, scientists and administrators have worked hard to fill gaps and needs in COVID-19 testing, making measurable, remarkable progress, moving from crisis mode in early days to a broader, more thoughtful approach that addresses not just the continuing and urgent needs of patients, staff and students, but the wellness and future of the larger community. Read the full story.
  • (4/3/20) Qualcomm Institute Lends its Prototyping and 3D Printing Capabilities for Critical Medical SuppliesUC San Diego’s Qualcomm Institute (QI) is drawing on its unique range of expertise and technology to help in the rapid prototyping and development of medical supplies desperately needed in the fight against the COVID-19 pandemic. Read the full story.
  • (4/2/20) Dissecting COVID-19: Biology Professor Opens Infectious Disease Course to Public Audiences: Biological Sciences Assistant Professor Justin Meyer’s spring 2020 course, “Evolution of Infectious Diseases,” will be available on UCTV and other public platforms. Read the full story.
  • (4/2/20) Creating an Early Alert System for COVID-19Researchers combine power of wearable device and big data analytics to track spread and early signs of infection—including among healthcare workers. Read the full story.

  • (3/26/20) UC San Diego Engineers and Doctors Team Up to Retrofit and Build Ventilators with 3D-Printing: A team of engineers and physicians at the University of California San Diego is rapidly developing simple, ready-to-use ventilators to be deployed if the need arises. Read the full story.
  • (3/24/20) UC San Diego Health Launches Clinical Trial to Assess Antiviral Drug for COVID-19: With three other UC Health medical centers, NIH-sponsored trial will study whether remdesivir, an investigational antiviral drug, may be a safe and effective agent against the novel coronavirus that causes COVID-19. Read the full story.
  • (3/20/20) UC San Diego Partners with 5 Leading Diagnostics Manufacturers to Boost COVID-19 Testing: Spurred by need and urgency, unprecedented collaboration will increase testing capacity to 1,000 to 1,500 tests per day within 2 to 3 weeks. Read the full story.